These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 35949770)
1. Efficacy and Safety of Colchicine in Prevention of Secondary Cardiovascular Outcomes Among Patients With Coronary Vessel Disease: A Meta-Analysis. Sattar L; Memon RA; Ashfaq F; Hamdani SSQ; Rahim Vohra R; Ashraf J; Khan B; Khurshid Ahmed N; Khan A Cureus; 2022 Jul; 14(7):e26680. PubMed ID: 35949770 [TBL] [Abstract][Full Text] [Related]
2. Colchicine for Secondary Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Samuel M; Tardif JC; Bouabdallaoui N; Khairy P; Dubé MP; Blondeau L; Guertin MC Can J Cardiol; 2021 May; 37(5):776-785. PubMed ID: 33075455 [TBL] [Abstract][Full Text] [Related]
3. Colchicine may become a new cornerstone therapy for coronary artery disease: a meta-analysis of randomized controlled trials. Chen Y; Zhang H; Chen Y; Li M; Luo W; Liu Y; Fu Y; Xia H; Xu C; Jiang Y; Wu Y Clin Rheumatol; 2022 Jun; 41(6):1873-1887. PubMed ID: 35138464 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of colchicine for the prevention of major cardiovascular and cerebrovascular events in patients with coronary artery disease: a systematic review and meta-analysis on 12 869 patients. Andreis A; Imazio M; Piroli F; Avondo S; Casula M; Paneva E; De Ferrari GM Eur J Prev Cardiol; 2022 Feb; 28(17):1916-1925. PubMed ID: 33779702 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials. Fiolet ATL; Opstal TSJ; Mosterd A; Eikelboom JW; Jolly SS; Keech AC; Kelly P; Tong DC; Layland J; Nidorf SM; Thompson PL; Budgeon C; Tijssen JGP; Cornel JH Eur Heart J; 2021 Jul; 42(28):2765-2775. PubMed ID: 33769515 [TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis of Randomized Trials: Efficacy and Safety of Colchicine for Secondary Prevention of Cardiovascular Disease. Akl E; Sahami N; Labos C; Genest J; Zgheib A; Piazza N; Jolly S J Interv Cardiol; 2024; 2024():8646351. PubMed ID: 38505729 [TBL] [Abstract][Full Text] [Related]
8. Colchicine for cardiovascular medicine: a systematic review and meta-analysis. Casula M; Andreis A; Avondo S; Vaira MP; Imazio M Future Cardiol; 2022 Aug; 18(8):647-659. PubMed ID: 35787150 [TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis. Wang H; Jiang M; Li X; Zhao Y; Shao J; Liu Z; Lin L; Xu Q; Wang L; Lu X; Zhang H; Chen Y; Zhang R Front Cardiovasc Med; 2021; 8():726341. PubMed ID: 34513960 [No Abstract] [Full Text] [Related]
10. Efficacy and Safety of Colchicine in Post-acute Myocardial Infarction Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Diaz-Arocutipa C; Benites-Meza JK; Chambergo-Michilot D; Barboza JJ; Pasupuleti V; Bueno H; Sambola A; Hernandez AV Front Cardiovasc Med; 2021; 8():676771. PubMed ID: 34169101 [No Abstract] [Full Text] [Related]
11. Colchicine in the Management of Acute Coronary Syndrome: A Meta-analysis. Nogic J; Mehta O; Tong D; Brown AJ; Layland J Cardiol Ther; 2023 Mar; 12(1):171-181. PubMed ID: 36609745 [TBL] [Abstract][Full Text] [Related]
12. Meta-analysis Evaluating the Utility of Colchicine in Secondary Prevention of Coronary Artery Disease. Xia M; Yang X; Qian C Am J Cardiol; 2021 Feb; 140():33-38. PubMed ID: 33137319 [TBL] [Abstract][Full Text] [Related]
13. Tongxinluo capsule as supplementation and cardiovascular endpoint events in patients with coronary heart disease: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials. Lv J; Liu S; Guo S; Gao J; Song Q; Cui X J Ethnopharmacol; 2022 May; 289():115033. PubMed ID: 35091010 [TBL] [Abstract][Full Text] [Related]
14. Colchicine for Secondary Prevention of Coronary Artery Disease: A Meta-Analysis of Randomised Controlled Trials. Xu H; Mao L; Liu H; Lin Z; Zhang Y; Yang J Heart Lung Circ; 2022 May; 31(5):685-695. PubMed ID: 35033433 [TBL] [Abstract][Full Text] [Related]
15. Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials. Ma Z; Chen J; Jin K; Chen X Front Cardiovasc Med; 2022; 9():947959. PubMed ID: 36176989 [TBL] [Abstract][Full Text] [Related]
16. Effects of Colchicine on Cardiovascular Outcomes in Patients with Coronary Artery Disease: A Systematic Review and One-Stage and Two-Stage Meta-Analysis of Randomized-Controlled Trials. Teo YN; Teo YH; Syn NL; Goh MW; Yoong CSY; Lee CH; Chan MY; Chai P; Yeo TC; Sia CH High Blood Press Cardiovasc Prev; 2021 Jul; 28(4):343-354. PubMed ID: 34003455 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of colchicine for secondary prevention of coronary heart disease: a systematic review and meta-analysis. Xiang Z; Yang J; Yang J; Zhang J; Fan Z; Yang C; Di L; Ma C; Wu J; Huang Y Intern Emerg Med; 2021 Mar; 16(2):487-496. PubMed ID: 33400158 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of colchicine in patients with coronary artery disease: A systematic review and meta-analysis of randomized controlled trials. Bytyçi I; Bajraktari G; Penson PE; Henein MY; Banach M; ; Br J Clin Pharmacol; 2022 Feb; 88(4):1520-1528. PubMed ID: 34409634 [TBL] [Abstract][Full Text] [Related]
19. Colchicine for Secondary Cardiovascular Prevention: A Systematic Review. Webb CA; Barry AR Pharmacotherapy; 2020 Jun; 40(6):575-583. PubMed ID: 32259308 [TBL] [Abstract][Full Text] [Related]